Skip to main content
Veterinary Medicines

Libromide 325 mg tablets for dogs

Authorised
  • Potassium bromide

Product identification

Medicine name:
Libromide 325 mg tablets for dogs
Libromide 325 mg Tabletten für Hunde
Active substance:
  • Potassium bromide
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium bromide
    325.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM11
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-01171
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0507/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/08/2024
Updated on: 2/09/2024

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
German (PDF)
Published on: 14/11/2023
Updated on: 2/09/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 1/03/2019
Updated on: 2/09/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."